- Home
- MGYR vs IMAB Comparison
MGYR vs IMAB Comparison
Compare MGYR & IMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGYR
- IMAB
- Stock Information
- Founded
- MGYR 1922
- IMAB 2014
- Country
- MGYR United States
- IMAB United States
- Employees
- MGYR N/A
- IMAB N/A
- Industry
- MGYR Savings Institutions
- IMAB Biotechnology: Pharmaceutical Preparations
- Sector
- MGYR Finance
- IMAB Health Care
- Exchange
- MGYR Nasdaq
- IMAB Nasdaq
- Market Cap
- MGYR 94.2M
- IMAB 83.8M
- IPO Year
- MGYR 2006
- IMAB 2020
- Fundamental
- Price
- MGYR $14.65
- IMAB $0.92
- Analyst Decision
- MGYR
- IMAB Strong Buy
- Analyst Count
- MGYR 0
- IMAB 3
- Target Price
- MGYR N/A
- IMAB $8.00
- AVG Volume (30 Days)
- MGYR 7.8K
- IMAB 452.7K
- Earning Date
- MGYR 01-23-2025
- IMAB 08-28-2024
- Dividend Yield
- MGYR 1.64%
- IMAB N/A
- EPS Growth
- MGYR 2.51
- IMAB N/A
- EPS
- MGYR 1.23
- IMAB N/A
- Revenue
- MGYR $31,497,000.00
- IMAB $3,313,984.00
- Revenue This Year
- MGYR N/A
- IMAB N/A
- Revenue Next Year
- MGYR N/A
- IMAB N/A
- P/E Ratio
- MGYR $11.91
- IMAB N/A
- Revenue Growth
- MGYR 4.87
- IMAB N/A
- 52 Week Low
- MGYR $10.30
- IMAB $0.90
- 52 Week High
- MGYR $14.74
- IMAB $2.54
- Technical
- Relative Strength Index (RSI)
- MGYR 62.55
- IMAB 38.53
- Support Level
- MGYR $14.08
- IMAB $0.90
- Resistance Level
- MGYR $14.50
- IMAB $0.98
- Average True Range (ATR)
- MGYR 0.31
- IMAB 0.07
- MACD
- MGYR -0.03
- IMAB -0.00
- Stochastic Oscillator
- MGYR 90.82
- IMAB 10.00
About MGYR Magyar Bancorp Inc.
Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).